5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.05%
Negative revenue growth while VALMT.HE stands at 31.34%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.86%
Negative gross profit growth while VALMT.HE is at 20.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
-35.47%
Negative EBIT growth while VALMT.HE is at 30.23%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.47%
Negative operating income growth while VALMT.HE is at 30.23%. Joel Greenblatt would press for urgent turnaround measures.
-39.09%
Negative net income growth while VALMT.HE stands at 22.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-41.18%
Negative EPS growth while VALMT.HE is at 23.81%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-41.18%
Negative diluted EPS growth while VALMT.HE is at 23.81%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
3.54%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.54%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-15.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-54.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.54%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 72.68%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-7.94%
Negative 5Y CAGR while VALMT.HE stands at 64.75%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.17%
3Y revenue/share CAGR above 1.5x VALMT.HE's 13.19%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
240.15%
Positive long-term OCF/share growth while VALMT.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-68.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
247.30%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
134.89%
Below 50% of VALMT.HE's 2500.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
105.96%
Below 50% of VALMT.HE's 271.43%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
66.67%
3Y net income/share CAGR above 1.5x VALMT.HE's 23.81%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
46.50%
5Y equity/share CAGR above 1.5x VALMT.HE's 23.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.39%
3Y equity/share CAGR above 1.5x VALMT.HE's 7.64%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
233.14%
5Y dividend/share CAGR at 50-75% of VALMT.HE's 374.06%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
81.82%
3Y dividend/share CAGR similar to VALMT.HE's 88.41%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-3.07%
Firm’s AR is declining while VALMT.HE shows 23.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.73%
Inventory shrinking or stable vs. VALMT.HE's 17.09%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.96%
Negative asset growth while VALMT.HE invests at 0.89%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.70%
We have a declining book value while VALMT.HE shows 4.78%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.05%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
9.57%
SG&A growth well above VALMT.HE's 19.08%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.